STAT3 gain-of-function variants and T cell-mediated inflammation

被引：0

作者：

Toth, Kelsey A. ^{[1
]}

Saucier, Nermina ^{[1
]}

Agbigbe, Tejiri ^{[1
]}

Schmitt, Erica ^{[1
]}

Keppel, Molly P. ^{[1
]}

Klechevsky, Eynav ^{[1
]}

Kim, Brian ^{[1
]}

Cooper, Megan A. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

来源：

JOURNAL OF IMMUNOLOGY | 2021年 / 206卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

61.14

引用

页数：2

共 50 条

[21] A human STAT3 gain-of-function variant drives local Th17 dysregulation and skin inflammation in mice
Toth, Kelsey A.
Schmitt, Erica G.
Kolicheski, Ana
Greenberg, Zev J.
Levendosky, Elizabeth
Saucier, Nermina
Trammel, Kelsey
Oikonomou, Vasileios
Lionakis, Michail S.
Klechevsky, Eynav
Kim, Brian S.
Schuettpelz, Laura G.
Saligrama, Naresha
Cooper, Megan A.
JOURNAL OF EXPERIMENTAL MEDICINE, 2024, 221 (08):
[22] Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function associated Multi-organ Autoimmune Syndrome
Khoury, Tawfik
Molho-Pessach, Vered
Ramot, Yuval
Ayman, Abu Rmeileh
Elpeleg, Orly
Berkman, Neville
Zlotogorski, Abraham
Ilan, Yaron
CLINICAL THERAPEUTICS, 2017, 39 (02) : 444 - 449
[23] Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK Inhibitors
Carmona, M. D. Silva
Vogel, T.
Marchal, S.
Guesmi, M.
Dubus, J.
Baravalle, M.
Leroy, S.
Marquette, C.
Fabre, A.
Barlogis, V.
Leiding, J.
Forbes, L.
Giovannini-Chami, L.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[24] Janus kinase inhibitors ameliorate clinical symptoms in patients with STAT3 gain-of-function
Kaneko, Shuya
Sakura, Fumiaki
Tanita, Kay
Shimbo, Asami
Nambu, Ryusuke
Yoshida, Masashi
Umetsu, Shuichiro
Inui, Ayano
Okada, Chizuru
Tsumura, Miyuki
Yamada, Mamiko
Suzuki, Hisato
Kosaki, Kenjiro
Ohara, Osamu
Shimizu, Masaki
Morio, Tomohiro
Okada, Satoshi
Kanegane, Hirokazu
IMMUNOTHERAPY ADVANCES, 2023, 3 (01):
[25] Cutting Edge: Systemic Autoimmunity in Murine STAT3 Gain-of-Function Syndrome Is Characterized by Effector T Cell Expansion in the Absence of Overt Regulatory T Cell Dysfunction
Woods, Jonathan
Pemberton, Sarah E.
Largent, Andrea D.
Chiang, Kristy
Liggitt, Denny
Oukka, Mohamed
Rawlings, David J.
Jackson, Shaun W.
JOURNAL OF IMMUNOLOGY, 2022, 209 (06): : 1033 - 1038
[26] De novo mutations promote inflammation in children with STAT3 gain-of-function syndrome by affecting IL-1β expression
Chen, Ji-Yu
Li, Yan-Fang
Zhou, Zhu
Jiang, Xue-Mei
Bi, Xin
Yang, Mi-Feng
Zhao, Bo
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 140
[27] GAIN-OF-FUNCTION STAT1 MUTATIONS ALTER STAT3 ACTIVATION IN PATIENTS WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS
Zheng, J.
Rowan, A. D.
Gennery, A. R.
Abinun, M.
Lilic, D.
JOURNAL OF CLINICAL IMMUNOLOGY, 2012, 32 : 203 - 203
[28] Mutual antagonism of STAT1 and STAT3 controls T cell-mediated hepatitis: Regulation by SOCS.
Gao, B
Hong, F
Jaruga, B
Radaeva, S
Tian, ZG
Nguyen, VA
HEPATOLOGY, 2002, 36 (04) : 476A - 476A
[29] Efficacy of Ruxolitinib Therapy in a Patient With Severe Enterocolitis Associated With a STAT3 Gain-of-Function Mutation
Parlato, Marianna
Charbit-Henrion, Fabienne
Elie, Abi Nader
Begue, Bernadette
Guegan, Nicolas
Bruneau, Julie
Khater, Sherine
Macintyre, Elizabeth
Picard, Capucine
Frederic, Rieux-Laucat
Le Bourhis, Lionel
Allez, Matthieu
Goulet, Olivier
Cellier, Christophe
Hermine, Olivier
Cerf-Bensussan, Nadine
Malamut, Georgia
GASTROENTEROLOGY, 2019, 156 (04) : 1206 - +
[30] Efficacy of tocilizumab therapy in a patient with severe pancytopenia associated with a STAT3 gain-of-function mutation
Wang, Wenjie
Liu, Luyao
Hui, Xiaoying
Wang, Ying
Ying, Wenjing
Zhou, Qinhua
Hou, Jia
Yang, Mi
Sun, Bijun
Sun, Jinqiao
Wang, Xiaochuan
BMC IMMUNOLOGY, 2021, 22 (01)

← 1 2 3 4 5 →